The favorable prognostic significance of atelectasis in patients with advanced non-small cell lung cancer: Results of a prospective observational study

Lung Cancer

Volumn 63, Issue 2, 2009, Pages 271-276

  Dediu, Mircea ^a   Crisan, Emilia ^b   Radut, Maria ^a   Tarlea, Alin ^a   Median, Dragos ^a   Alexandru, Aurelia ^a   Vremes, Georgeta ^a   Gal, Cristian ^a  

^a Institutul Oncologic Prof Dr Alexandru Trestioreanu Bucuresti   (Romania)

^b National Institute of Pneumology Marius Nasta   (Romania)

Author keywords

Atelectasis; NSCLC; Prognosis; TNM staging system

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; GEMCITABINE; NAVELBINE; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; ATELECTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY ATELECTASIS;

EID: 58049217018     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2008.05.007     Document Type: Article

References (26)

1. Mountain C.F. Revision in the International System for Staging Lung Cancer. Chest 111 (1997) 1710-1717
2. Ou I., Zell J., Ziogas A., and Anton-Culver H. Prognostic significance of the non-size based AJCC T2 descriptors: visceral pleural invasion (VPI), hilar atelectasis or obstructive pneumonitis in stage IB non-small cell lung cancer (NSCLC) is dependent on tumor size. Chest 133 (2008) 662-669
3. Jones D.R., Daniel T.M., Denlinger C.E., Rundall B., Smolkin M., and Wick M. Stage IB non-small cell lung cancer: are they all the same?. Ann Thorac Surg 81 (2006) 1958-1962
4. Yilmaz B., Oztuna F., Tobpa M., and Ozlu T. Survival analysis of patients with thoracic complications secondary to bronchial carcinoma at the time of diagnosis. Respiration 72 (2005) 388-394
5. Coen V., Van Lancker M., De Neve W., and Storme G. Prognostic factors in locoregional non-small cell lung cancer treated with radiotherapy. Am J Clin Oncol 18 (1995) 111-117
6. www.SPSS.com
7. Ball D., Fisher R., Burmeister B., Graham P., Joseph D., Penniment M., et al. Stage is not a reliable indicator of tumor volume in non-small cell lung cancer: a preliminary analysis of the trans-Tasman Radiation Oncology Group 99-05 Database. J Thorac Oncol 1 (2006) 667-672
8. Mountain C.F., Carr D.T., and Anderson W.A.D. A system for the clinical staging of lung cancer. Am J Roentogenol Rad Ther Nucl Med 120 (1974) 130-138
9. Proto A. Lobar collapse: basic concepts. Eur J Radiol 23 (1996) 9-22
10. Ashizawa K., Hayashi K., Aso N., and Minami K. Lobar atelectasis: diagnostic pitfalls on chest radiology. Br. J. Radiol. 74 (2001) 89-97
11. Woodring J. Determining the cause of pulmonary atelectasis: a comparison of plain radiography and CT. AJR 150 (1988) 757-763
12. Peroni D.G., and Boner A.L. Atelectasis: mechanisms, diagnosis and management. Pediatr Respir Rev 1 (2000) 274-278
13. Sharma S, Mayckes B, Tsuiuki S. Atelectasis. Lobar. http://www.emedicine.com/RADIO/topic64.htm. Last update: January 10, 2007.
14. Sharma S., Maycher B., and Eschun G. Radiological imaging in pneumonia: recent innovations. Curr Opin Pulm Med 13 (2007) 159-169
15. Shepherd F., Ginsberg R., Haddad R., Feld R., Sagman U., Evans W., et al. Importance of clinical staging in limited small cell lung cancer: a valuable system to separate prognostic subgroups. J Clin Oncol 11 (1993) 1592-1597
16. Engoren M. Lack of association between atelectasis and fever. Chest 107 (1995) 81-84
17. Clarke D.E., Kimelman J., and Raffin T.A. The evaluation of fever in the intensive care unit. Chest 100 (1991) 213-220
18. Roberts J., Barnes W., Pennock B., and Browne G. Diagnostic accuracy of fever as a measure of postoperative pulmonary complications. Heart Lung 17 (1988) 166-170
19. Bradley J.D., Ieumwanananonthachai N., Purdy J.A., Wasserman T.H., Lockett M.A., Graham M.U., et al. Gross tumor volume critical prognostic factor in patients treated with three dimensional conformal radiation therapy for non-small cell lung cancer. Int J Radiat Oncol Biol Phys 52 (2002) 49-57
20. Slotman B.J., Njo K.H., and Karim A. Curative radiotherapy for technically operable stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 29 (1994) 33-37
21. Kaskowitz L., Graham M.V., Emami B., Halverson K.J., and Rush C. Radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 27 (1993) 517-523
22. Umeki S., Okimoto N., and Soejima R. Atelectatic lung escaping radiation pneumonitis. Chest 101 (1992) 879-880
23. Mountain C.F. A new international staging system for lung cancer. Chest 89 (1986) 225-233
24. Goldstraw P., Crowley J., Chansky K., Giroux D., Groome P., Rami-Porta R., et al. The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumors. J Thorac Oncol 2 (2007) 706-714
25. Rami-Porta R., Ball D., Crowley J., Giroux D., Jett J., William T., et al. IASLC Staging System Project: T-descriptors. J Thorac Oncol 2 (2007) S227-S228
26. Sculier J.P. IASLC staging project: prognostic factors. J Thorac Oncol 2 (2007) S229-S230